Literature DB >> 23806559

Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Alfredo Ulloa-Aguirre1, Teresa Zariñán2, James A Dias3, P Michael Conn4.   

Abstract

G protein coupled receptors (GPCRs) are a large superfamily of integral cell surface plasma membrane proteins that play key roles in transducing extracellular signals, including sensory stimuli, hormones, neurotransmitters, or paracrine factors into the intracellular environment through the activation of one or more heterotrimeric G proteins. Structural alterations provoked by mutations or variations in the genes coding for GPCRs may lead to misfolding, altered plasma membrane expression of the receptor protein and frequently to disease. A number of GPCRs regulate reproductive function at different levels; these receptors include the gonadotropin-releasing hormone receptor (GnRHR) and the gonadotropin receptors (follicle-stimulating hormone receptor and luteinizing hormone receptor), which regulate the function of the pituitary-gonadal axis. Loss-of-function mutations in these receptors may lead to hypogonadotropic or hypergonadotropic hypogonadism, which encompass a broad spectrum of clinical phenotypes. In this review we describe mutations that provoke misfolding and failure of these receptors to traffick from the endoplasmic reticulum to the plasma membrane. We also discuss some aspects related to the therapeutic potential of some target-specific drugs that selectively bind to and rescue function of misfolded mutant GnRHR and gonadotropin receptors, and that represent potentially valuable strategies to treat diseases caused by inactivating mutations of these receptors.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptors; Gonadotropin receptors; Gonadotropin-releasing hormone receptor; Hipogonadism; Intracellular trafficking; Pharmacological chaperones

Mesh:

Substances:

Year:  2013        PMID: 23806559      PMCID: PMC3844050          DOI: 10.1016/j.mce.2013.06.024

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  162 in total

Review 1.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  Molecular, structural, and cellular biology of follitropin and follitropin receptor.

Authors:  James A Dias; Brian D Cohen; Barbara Lindau-Shepard; Cheryl A Nechamen; Andrew J Peterson; Anja Schmidt
Journal:  Vitam Horm       Date:  2002       Impact factor: 3.421

3.  Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene.

Authors:  A Richter-Unruh; J W M Martens; M Verhoef-Post; H T Wessels; W A Kors; G H G Sinnecker; A Boehmer; S L S Drop; S P A Toledo; H G Brunner; A P N Themmen
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

4.  Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist.

Authors:  Claire L Newton; Adele M Whay; Craig A McArdle; Meilin Zhang; Chris J van Koppen; Ruud van de Lagemaat; Deborah L Segaloff; Robert P Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

5.  New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.

Authors:  P Touraine; I Beau; A Gougeon; G Meduri; A Desroches; C Pichard; M Detoeuf; B Paniel; M Prieur; J R Zorn; E Milgrom; F Kuttenn; M Misrahi
Journal:  Mol Endocrinol       Date:  1999-11

6.  FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia.

Authors:  Lawrence C Layman; Adriana L A Porto; Jun Xie; Luiz Augusto Casulari Roxo da Motta; Lucilia Domingues Casulari da Motta; Weishui Weiser; Patrick M Sluss
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.

Authors:  Alfredo Leaños-Miranda; Alfredo Ulloa-Aguirre; Tae H Ji; Jo Ann Janovick; P Michael Conn
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

8.  Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.

Authors:  Jo Ann Janovick; Guadalupe Maya-Nunez; P Michael Conn
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  Mice harboring Gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure.

Authors:  M David Stewart; Jian Ming Deng; C Allison Stewart; Rachael D Mullen; Ying Wang; Suhujey Lopez; M Katalina Serna; Cheng-Chiu Huang; Jo Ann Janovick; Andrew J Pask; Robert J Schwartz; P Michael Conn; Richard R Behringer
Journal:  Mol Endocrinol       Date:  2012-08-23

10.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

View more
  12 in total

1.  A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.

Authors:  Camilo J Morfa; Daniel Bassoni; Andras Szabo; Danielle McAnally; Haleli Sharir; Becky L Hood; Stefan Vasile; Tom Wehrman; Jane Lamerdin; Layton H Smith
Journal:  Assay Drug Dev Technol       Date:  2018-09-22       Impact factor: 1.738

2.  "Been hit twice": a novel bi-allelic heterozygous mutation in LHCGR.

Authors:  T Rajendra Kumar
Journal:  J Assist Reprod Genet       Date:  2014-07       Impact factor: 3.412

Review 3.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

4.  Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.

Authors:  Verònica Casadó-Anguera; Estefanía Moreno; Josefa Mallol; Sergi Ferré; Enric I Canela; Antoni Cortés; Vicent Casadó
Journal:  Pharmacol Res       Date:  2018-11-22       Impact factor: 7.658

5.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

Review 6.  Pharmacological chaperoning: a primer on mechanism and pharmacology.

Authors:  Nancy J Leidenheimer; Katelyn G Ryder
Journal:  Pharmacol Res       Date:  2014-02-14       Impact factor: 7.658

7.  Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity.

Authors:  Emery Smith; Jo Ann Janovick; Thomas D Bannister; Justin Shumate; Vadivel Ganapathy; Louis Scampavia; Timothy P Spicer
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 8.  Studying Staphylococcal Leukocidins: A Challenging Endeavor.

Authors:  Angelino T Tromp; Jos A G van Strijp
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

Review 9.  Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Eduardo Jardón-Valadez
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 10.  Strategies for Site-Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags.

Authors:  Philipp Wolf; Georgina Gavins; Annette G Beck-Sickinger; Oliver Seitz
Journal:  Chembiochem       Date:  2021-02-26       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.